Equifax enters the back half of May with its stock down 18% on the month, CEO-level selling on the books, and short interest quietly building — a combination that puts the bears in a stronger position than they have been all year.
The insider activity is the sharpest signal this week. CEO Mark Begor sold more than 37,000 shares on April 24 across four transactions, collecting roughly $5.7 million at prices around $172–$174. CFO John Gamble followed with a 3,500-share sale on May 1. Both transactions came after the stock had already absorbed a brutal earnings reaction — down nearly 10% on April 21 and a further 13.5% over the subsequent five days. With the stock now trading at $160.83, those sales look well-timed. The 90-day net insider position clocks in at a net sell of approximately $18.6 million in value, with almost no countervailing buy activity at the senior level (one EVP buy in February is the exception).
Short interest has been creeping higher alongside the price decline. SI % of free float has risen from around 4.1% in mid-April to roughly 4.7–4.8% now — a gain of about 19% in absolute share terms over the past month. That is a meaningful acceleration, though the level itself remains moderate rather than extreme. Borrow conditions offer no constraint to new shorts: availability is running at 1,259%, meaning there are more than twelve shares available to borrow for every one already shorted. Cost to borrow is just 0.41%, among the cheapest in the market. The lending pool is wide open, and the ORTEX short score at 40.7 reflects a position that is building but not yet crowded.
Options positioning has shifted notably in the opposite direction from what the price action might suggest. The put/call ratio at 0.87 is running roughly one standard deviation below its 20-day average of 0.97 — the least defensive options positioning seen on the name since this spring. That divergence from the bear story in short interest is worth flagging. Either options traders are fading the selloff as overdone, or the hedging community rotated out of puts after the earnings event already captured the downside. Either way, options are not corroborating the short-side buildup.
The Street remains constructive but is trimming ambitions. BofA — as recently as yesterday — maintained its Buy rating while cutting its target from $250 to $225. UBS, Wells Fargo, and Baird all lowered targets in the days following the April 21 earnings reaction, though none dropped their positive ratings. The mean price target of $226 implies roughly 41% upside from current levels — a wide gap that reflects either genuine conviction or targets that have not fully caught up with the new price reality. Goldman Sachs sits at Neutral with a $208 target, the outlier in a predominantly bullish analyst community. The bull case rests on mortgage volume recovery and FICO price increases; the bear case points to deteriorating origination volumes, slowing international growth, and lingering reputational drag from the 2017 breach.
Valuation has compressed sharply. The P/E multiple has fallen roughly 4.4 points over 30 days to 17.4x, and EV/EBITDA is down about 0.3 turns to 10.9x. Those moves reflect a stock re-rating in real time, not just a price drift. Closest peer TransUnion fell 4.5% on the week, in line with EFX's 3.6% drop, confirming sector-level pressure rather than an EFX-specific headline. SS&C Technologies was broadly flat on the week, suggesting the pain is concentrated in the credit data names.
With no confirmed next earnings event in the snapshot and the stock trading at a 27% year-to-date discount, the next catalyst to watch is any macro data point touching mortgage origination volumes — the variable that most directly bridges the gap between the Street's targets and what the market is currently pricing in.
See the live data behind this article on ORTEX.
Open EFX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
